March 31, 2026

NovoCure Limited (NVCR) Stock Analysis: Exploring a 151.65% Potential Upside in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the medical device industry, is capturing investor attention with its innovative approach to cancer treatment and a substantial potential upside of 151.65%,..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring the 175% Potential Upside in the Biotech Arena

Biohaven Ltd. (BHVN), a prominent player in the biotechnology sector, is making waves with a potential upside of 175.03%, as indicated by its average target price of $22.25. This is..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Play with a 62.92% Upside Potential

Investors with a keen interest in the biotechnology sector might want to keep a close eye on Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT). With a market capitalization of $2.65 billion, this..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 58.98% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is drawing significant attention within the biotechnology sector due to its promising pipeline and strategic alliances. With a market capitalization of $2.76 billion, IDEAYA stands..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Navigating Growth Potential Amidst Market Challenges

Investors eyeing the healthcare sector might want to pay close attention to PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering player in the medical devices industry. With a market capitalization of..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: A Potential 57% Upside Amidst Market Challenges

For investors looking to navigate the complexities of the medical device sector, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) presents a unique opportunity. Specializing in cutting-edge diabetes management solutions, Tandem is..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: 40% Upside Potential with Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a key player in the healthcare industry, stands out in the drug manufacturing sector, particularly in the specialty and generic drug markets. Despite its current..

Clover Health Investments (CLOV) Stock Analysis: Unpacking the 63.76% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV) has been a noteworthy player in the healthcare sector, specifically within the healthcare plans industry. Based in Wilmington, Delaware, Clover Health offers Medicare Advantage..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating the Peaks and Valleys of Biotech Investing

Arcellx, Inc. (NASDAQ: ACLX) presents itself as a compelling yet challenging opportunity for investors in the biotechnology sector. With a market capitalization of $6.71 billion, Arcellx is a significant player..

Immunocore Holdings plc (IMCR)

⚠️ No article content returned.

..

Alvotech (ALVO) Stock Analysis: Exploring a 325% Upside Potential in the Biosimilar Market

Investors looking for opportunities in the healthcare sector might find Alvotech (NASDAQ: ALVO) an intriguing prospect. This Luxembourg-based company, with a market cap of $1.03 billion, is making significant strides..

BGM Group Ltd. (BGM) Stock Analysis: Examining the Healthcare Manufacturer’s Challenging Financial Landscape

BGM Group Ltd. (BGM), a healthcare sector player based in China, operates within the specialty and generic drug manufacturing industry. Despite its strategic positioning in the lucrative pharmaceutical market, BGM’s..

SS Innovations International (SSII): Navigating Growth in the Healthcare Sector with a 79.10% Revenue Surge

SS Innovations International, Inc. (SSII), a burgeoning entity in the healthcare sector, has garnered attention with its significant revenue growth of 79.10%. Though this Indian-based medical devices company operates on..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 53% Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, is currently generating buzz among investors. With its..

Immunovant, Inc. (IMVT) Stock Analysis: A Promising 70.60% Upside Potential in Biotech

Investors are increasingly turning their attention to Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company focused on developing monoclonal antibodies for autoimmune diseases. With a market capitalization of $4.79 billion..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a Potential 62% Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY), operating within the robust healthcare sector, specifically in the medical care facilities industry, presents an intriguing opportunity for investors seeking exposure to the burgeoning demand..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 115.50% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the healthcare sector, offers investors a unique opportunity to delve into the rapidly evolving biotechnology industry. Headquartered in Pudong, China, this..

Schrodinger, Inc. (SDGR) Stock Analysis: A Look at 108.77% Potential Upside and Investor Ratings

Schrodinger, Inc. (NASDAQ: SDGR) operates at the cutting-edge intersection of technology and healthcare, leveraging its proprietary computational platform to revolutionize drug discovery and materials science. As investors evaluate the potential..

Crinetics Pharmaceuticals, Inc. (CRNX) Consensus: Uncovering a Potential 143.65% Upside in Biotech Innovation

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is at the forefront of innovation in the biotechnology sector, with a focus on developing novel therapeutics for rare endocrine diseases and endocrine-related tumors. The..

Search

Funds

March 31, 2026

Search

Funds

March 31, 2026

FTSE 100

Funds